ロード中...

Cardioversion Safety − Are We Doing Enough?

There is a considerable periprocedural risk of thromboembolic events in atrial fibrillation patients undergoing cardioversion, and treatment with anticoagulants is therefore a hallmark of cardioversion safety. Based on retrospective subgroup analyses and prospective studies, non-vitamin K anticoagul...

詳細記述

保存先:
書誌詳細
出版年:Cardiology
主要な著者: Khatami, Mohsen, Pope, Marita Knudsen, Le Page, Sophie, Radic, Petra, Schirripa, Valentina, Grundvold, Irene, Atar, Dan
フォーマット: Artigo
言語:Inglês
出版事項: S. Karger AG 2020
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7677998/
https://ncbi.nlm.nih.gov/pubmed/32898849
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000509343
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!